Rekha Hemrajani
Direktor/Vorstandsmitglied bei MAXCYTE, INC.
Vermögen: 31 890 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jaume Pons | M | 58 |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | 9 Jahre |
Maher Masoud | M | 49 | - | |
Ron Holtz | M | 66 | 19 Jahre | |
Srini Akkaraju Akkaraju | M | 56 | 4 Jahre | |
Richard D. van Doren | M | 47 | 4 Jahre | |
Eric Morgen | M | - |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
Laurent Fischer | M | 60 | 4 Jahre | |
Jason Lettmann | M | 46 | 4 Jahre | |
Richard Douglas | M | 71 | 6 Jahre | |
Peter García | M | 62 | 4 Jahre | |
Kristen Fortney | M | - |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
Peter Soparkar | M | 53 | 5 Jahre | |
Graham Walmsley | M | 37 |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | 4 Jahre |
Patrick Haley | M | 48 | 14 Jahre | |
Steve Kelsey | M | 63 | 4 Jahre | |
Madhu Vikram Utamsingh | M | - |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | - |
Dawn Svoronos | F | 70 | 4 Jahre | |
Michael Giordano | M | 66 | 6 Jahre | |
Jason V. Coloma | M | - |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | 3 Jahre |
Linda Kozick | F | 66 | 8 Jahre | |
Yasir Al-Wakeel | M | 42 | 3 Jahre | |
David Sandoval | M | 46 | 1 Jahre | |
Reed Tuckson | M | 73 | 3 Jahre | |
Heikki Jouttijärvi | M | - | 4 Jahre | |
Corey Goodman | M | 72 | 9 Jahre | |
Patrick Balthrop | M | 67 | 2 Jahre | |
Scott Whitcup | M | 64 | 4 Jahre | |
Douglas Swirsky | M | 54 | 1 Jahre | |
Jack Wyszomierski | M | 68 | 20 Jahre | |
Art Mandell | M | 71 | 18 Jahre | |
George Poste | M | 79 | 20 Jahre | |
Mark Lupher | M | 53 | 5 Jahre | |
Dan Spiegelman | M | 65 | 4 Jahre | |
Will Brooke | M | 68 | 20 Jahre | |
Stanley Erck | M | 76 | 19 Jahre | |
Jim Scopa | M | 65 | 5 Jahre | |
John Johnston | M | 65 | 8 Jahre | |
Sophia Randolph | M | 56 | 8 Jahre | |
Gene Zhu | M | - | - | |
Suresh Chandumal Vazirani | M | - |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | - |
Hong I. Wan | M | - | 9 Jahre | |
Shelly Pinto | F | 48 | 3 Jahre | |
Bill Tan | M | - | 3 Jahre | |
Athanasios Tsiatis | M | - | 3 Jahre | |
Ali Soleymannezhad | M | - | 1 Jahre | |
Jill Mayer | F | - | 6 Jahre | |
Hank Stern | M | - | 9 Jahre | |
Dov Goldstein | M | 56 |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | 3 Jahre |
Dena House | F | - | 5 Jahre | |
Lisa Moore | M | - | 6 Jahre | |
Eric Matthews | M | - | 5 Jahre | |
Vijay Pande | M | 53 |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | - |
James Brady | M | - | - | |
Laura Dillard | F | - | 19 Jahre | |
Dirk Brockstedt | M | 55 | 6 Jahre | |
Chris Byrd | M | - | 2 Jahre | |
Michael Chang | M | - | 9 Jahre | |
Robert J. Adelman | M | 61 |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | - |
Steven Nardi | M | - | 4 Jahre | |
J. Garland | M | 55 | 2 Jahre | |
Thomas Ross | M | 63 | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Paul Cleveland | M | 67 | 4 Jahre | |
Jay Shepard | M | 66 | 7 Jahre | |
Doug Doerfler | M | 68 | 25 Jahre | |
Jennifer Cheng | M | 51 | 4 Jahre | |
Geoff Duyk | M | 64 | 7 Jahre | |
Jason Barker | M | 54 | 1 Jahre | |
David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
Christopher J. DeRespino | M | 43 | - | |
Angela Thedinga | F | 42 | 2 Jahre | |
Eric J. Hall | M | 69 | - | |
Lori Friedman | M | 60 | - | |
Robert Hoffman | M | 58 | 2 Jahre | |
Pamela Klein | M | 63 | - | |
James Bucher | M | 59 | 7 Jahre | |
Mohammed Malik | M | 56 | - | |
Myesha Lacy | F | - | - | |
Jack Nielsen | M | 60 | 4 Jahre | |
Jennifer Drimmer | F | - | 14 Jahre | |
Mitchell Finer | M | 65 | 13 Jahre | |
Cory Freedland | M | 48 | 2 Jahre | |
William Ringo | M | 78 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 Jahre |
Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 Jahre |
Francis McCormick | M | 73 | 11 Jahre | |
Perry Karsen | M | 69 | 1 Jahre | |
Christoph Pereira | M | 51 | 3 Jahre | |
Alan Garber | M | 68 | 19 Jahre | |
Richard Rodgers | M | 57 | 9 Jahre | |
Carl Feldbaum | M | 80 | 16 Jahre | |
Eric Carter | M | 72 | 4 Jahre | |
J. Stark Thompson | M | 82 | 20 Jahre | |
Antonio J. Grillo-López | M | 84 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 Jahre |
Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 Jahre |
Fred Eshelman | M | 76 | 4 Jahre | |
Glen Y. Sato | M | 65 | 4 Jahre | |
Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 Jahre |
Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 Jahre |
Itziar Canamasas | M | 50 | 2 Jahre | |
Mike Ouimette | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 98 | 98,00% |
Indien | 2 | 2,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Rekha Hemrajani
- Persönliches Netzwerk